Stoneridge Investment Partners Portfolio holdings
Top Buys
| 1 |
Wells Fargo
WFC
|
+$6.74M |
| 2 |
Boston Scientific
BSX
|
+$6.63M |
| 3 |
Abbott
ABT
|
+$2.34M |
| 4 |
Lam Research
LRCX
|
+$2.07M |
| 5 |
KLA
KLAC
|
+$1.56M |
Top Sells
| 1 |
PNC Financial Services
PNC
|
+$4.95M |
| 2 |
Zoetis
ZTS
|
+$2.74M |
| 3 |
Keurig Dr Pepper
KDP
|
+$1.94M |
| 4 |
W.R. Berkley
WRB
|
+$1.9M |
| 5 |
Zimmer Biomet
ZBH
|
+$1.74M |
Sector Composition
| 1 | Technology | 35.59% |
| 2 | Financials | 13.45% |
| 3 | Consumer Discretionary | 9.59% |
| 4 | Healthcare | 9.14% |
| 5 | Communication Services | 8.84% |
Similar funds
Stoneridge Investment Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Stoneridge Investment Partners held 156 positions worth $138M, down 3.8% from $144M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Stoneridge Investment Partners deployed $6.94M of net new capital in Q1 2026, opening 30 new positions and adding to 16 existing holdings. Its largest new stake was Wells Fargo: 78,459 shares worth $6.25M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was W.R. Berkley, an estimated $1.9M trimmed.
- Stoneridge Investment Partners's largest Q1 2026 buy was Wells Fargo: 78,459 shares worth $6.25M.
- Stoneridge Investment Partners added most to Huntington Bancshares in Q1 2026, an estimated $1.38M increase.
- Stoneridge Investment Partners's biggest Q1 2026 reduction was W.R. Berkley, cutting an estimated $1.9M.
- Stoneridge Investment Partners fully exited PNC Financial Services in Q1 2026, selling an estimated $4.95M.
- Stoneridge Investment Partners's ten largest holdings make up 41% of its $138M portfolio in Q1 2026.
- Stoneridge Investment Partners opened 30 new positions and closed 28 in Q1 2026.
- Stoneridge Investment Partners's portfolio value fell 3.8% quarter-over-quarter to $138M.
Based on Stoneridge Investment Partners's 13F filing for Q1 2026, filed 6 May 2026.